Avantor (NYSE:AVTR – Get Free Report) and Bullfrog AI (NASDAQ:BFRG – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation.
Institutional and Insider Ownership
95.1% of Avantor shares are owned by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are owned by institutional investors. 0.3% of Avantor shares are owned by insiders. Comparatively, 14.7% of Bullfrog AI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Volatility & Risk
Avantor has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of -2.6, indicating that its stock price is 360% less volatile than the S&P 500.
Profitability
This table compares Avantor and Bullfrog AI’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avantor | 5.08% | 9.79% | 4.74% |
| Bullfrog AI | N/A | -150.36% | -127.98% |
Analyst Ratings
This is a summary of recent recommendations for Avantor and Bullfrog AI, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avantor | 1 | 13 | 2 | 0 | 2.06 |
| Bullfrog AI | 1 | 1 | 0 | 0 | 1.50 |
Avantor currently has a consensus price target of $14.77, indicating a potential downside of 5.35%. Given Avantor’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Avantor is more favorable than Bullfrog AI.
Valuation and Earnings
This table compares Avantor and Bullfrog AI”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Avantor | $6.55 billion | 1.61 | -$530.20 million | $0.50 | 31.20 |
| Bullfrog AI | $120,000.00 | 85.44 | -$6.50 million | ($0.46) | -1.20 |
Bullfrog AI has lower revenue, but higher earnings than Avantor. Bullfrog AI is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.
Summary
Avantor beats Bullfrog AI on 11 of the 14 factors compared between the two stocks.
About Avantor
Avantor, Inc. is a global provider of products and services used in life sciences, advanced technology and applied materials. Its customers include biopharmaceutical and healthcare companies, laboratories, universities and manufacturers. The company supplies chemicals, reagents, laboratory consumables and equipment, as well as materials used in biopharmaceutical production. Avantor also provides services such as procurement, inventory management and support for laboratory and production operations.
About Bullfrog AI
BullFrog AI Holdings, Inc. is a biotechnology-focused artificial intelligence company that develops machine-learning tools for the healthcare and life sciences industries. The company’s work is centered on using artificial intelligence to analyze complex biomedical data and support more efficient approaches to drug development and precision medicine. Its primary technology platform, bfLEAP, is designed to process and interpret large datasets, including genomic and clinical information. BullFrog AI offers data analysis and related services intended to help pharmaceutical companies, biotechnology firms, researchers and other healthcare organizations identify patterns, potential biomarkers, patient subgroups and other insights that may inform therapeutic development.
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
